Psychiatric Squele of Sodium Valproate Versus Carbamazipine in Patients with Primary Generalized Epilepsy

Psychiatric Squele of Sodium Valproate Versus Carbamazipine in Patients with Primary Generalized Epilepsy

Background: psychiatric and behavioral side effects are common in patients with epilepsy and it may represent an intrinsic feature of the disease itself or a side effect of the antiepileptic use. Our aim in the present study is to assess the psychiatric side effects of Sodium Valproate and Carbamaz...

Full description

Bibliographic Details
Main Authors:	Zaki N. Hasan, AbdulR Al Yasiri, Hassan Aziz
Format:	Article
Language:	English
Published:	University of Baghdad/ Al-Kindy College of Medicine 2009-06-01
Series:	مجله كليه طب الكندي
Subjects:	antiepileptic drugs Sodium valproate Carbamazipine depression, anxiety psychiatric side effects.
Online Access:	https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/717

Similar Items

Psychiatric Squele of Sodium Valproate Versus Carbamazipine In Patients with Primary Generalized Epilepsy
by: Zeki Noah Hasan, et al.
Published: (2008-12-01)

Sodium Valproate Combined With Topiramate vs. Sodium Valproate Alone for Refractory Epilepsy: A Systematic Review and Meta-Analysis
by: Zhen-Ye Ji, et al.
Published: (2022-01-01)

Experimental study on the effects of simvastatin in reversing the femoral metaphyseal defects induced by sodium valproate in normal and ovariectomized rats
by: Yang Li, et al.
Published: (2022-09-01)

Sodium valproate-induced nocturnal enuresis in epilepsy: Three case reports and a review of the literature
by: Xiaorong Zhang, et al.
Published: (2023-03-01)

Epilepsy in Pregnancy—Management Principles and Focus on Valproate
by: Barbara Błaszczyk, et al.
Published: (2022-01-01)

Sodium Valproate Exacerbating an Underlying Disorder of Fatty Acid Metabolism
by: Jamie Bellinge, et al.
Published: (2016-09-01)

THERAPY FOR EPILEPSY IN MIDDLE-AGED AND ELDERLY PATIENTS
by: P. N. Vlasov, et al.
Published: (2009-03-01)

Anti-inflammatory Effect of Sodium Valproate on Carrageenan-Induced Paw Edema in Male Rat
by: mj Khoshnood, et al.
Published: (2008-12-01)

TREATMENT OF EPILEPSY IN CHILDREN: SPECIAL PHARMACEUTICAL FORMS
by: Е. D. Belousova
Published: (2016-08-01)

Valproate-induced hyperammonemic encephalopathy. A case report
by: A. Cerame, et al.
Published: (2022-06-01)

A description of sodium valproate, lamotrigine and levetiracetam consumption in the Western Cape public sector
by: Nicole Keuler, et al.
Published: (2022-06-01)

Use of valproate and carbamazepine in the therapy of epilepsy (guidelines for the practitioner)
by: P. N. Vlasov
Published: (2018-12-01)

Is there a universal drug for epilepsy?
by: S. G. Burd, et al.
Published: (2018-08-01)

The Therapeutic Effects of Low-Frequency Electrical Stimulations Adjunct to Sodium Valproate on Seizure and Behaviors
by: Raha Zalkhani, et al.
Published: (2020-01-01)

Psychiatric disorders in epilepsy. Communication II
by: v. a. Karlov
Published: (2017-02-01)

A pilot open-label study of oral acetazolamide for sodium valproate-associated weight gain in bipolar affective disorder
by: Mathews Joseph Panicker, et al.
Published: (2022-01-01)

Major Interaction between Warfarin and Na Valproate: A Case Report
by: Bizhan Kouchaki, et al.
Published: (2015-10-01)

Curcumin Ameliorates Sodium Valproate Induced Neurotoxicity through Suppressing Oxidative Stress and Preventing Mitochondrial Impairments
by: Sholeh Akbari, et al.
Published: (2022-10-01)

Hematological Side Effects of Valproate Used for the Treatment of Epilepsy
by: Pınar YILMAZBAŞ, et al.
Published: (2021-04-01)

Estimating the Optimal Dosage of Sodium Valproate in Idiopathic Generalized Epilepsy with Adaptive Neuro-Fuzzy Inference System
by: Amir Hooshang Mohammadpour, et al.
Published: (2012-07-01)

Estimating the Optimal Dosage of Sodium Valproate in Idiopathic Generalized Epilepsy with Adaptive Neuro-Fuzzy Inference System
by: Somayyeh Lotfi Noghabi, et al.
Published: (2012-07-01)

Sodium Valproate Use in Japanese Patients with Schizophrenia and Coronavirus Disease Is Associated with an Increased Risk of Pneumonia
by: Yusuke Arai, et al.
Published: (2023-09-01)

Treatment response to valproate in case with generalized anxiety disorder resistant to antidepressants
by: Sefa Vayısoğlu
Published: (2017-04-01)

Evaluation of sodium valproate levels in malnourished childhood epilepsy and its consequences
by: Vishwanath Reddy Gampala, et al.
Published: (2017-06-01)

Sodium Valproate Incompatibility with Parenteral Nutrition Admixtures—A Risk to Patient Safety: An In Vitro Evaluation Study
by: Ludwika Piwowarczyk, et al.
Published: (2022-02-01)

Sodium valproate-induced necrotizing pancreatitis in a patient with bipolar mania
by: Sripathi Santhosh Goud, et al.
Published: (2021-01-01)

Sodium Valproate-induced Adult-onset Type 2 Citrullinemia
by: Başak Elçin Ateş, et al.
Published: (2022-09-01)

Effect of methadone and valproate combination on morphine withdrawal-induced anxiety and depression in male mice
by: Vahidi S, et al.
Published: (2014-10-01)

Formulation of Sodium Valproate Nanospanlastics as a Promising Approach for Drug Repurposing in the Treatment of Androgenic Alopecia
by: Farid. A. Badria, et al.
Published: (2020-09-01)

Valproate-induced hypothyroidism in schizoaffective disorder
by: J. Facucho-Oliveira, et al.
Published: (2022-06-01)

Valproate in pregnancy: comment from the SAPP
by: Irene Hösli, et al.
Published: (2021-02-01)

Effect of Sodium Valproate, Oxcarbazepine and Levetiracetam on the Development of Different Functional Areas in Children with Epilepsy by Griffiths Development Scales-Chinese Edition
by: BAI Yanmin, DU Kaixian, CHEN Hao, JIA Tianming, GONG Huan, YU Shengyuan, LI Lin, GUAN Jing, ZHU Yingying
Published: (2023-08-01)

Syndrome of inappropriate antidiuretic hormone secretion caused by long-term use of sodium valproate： a case report and literature review
by: Chen Xueyan, Liang Fang, Xu Wen, Yang Xubin
Published: (2022-04-01)

Intraamygdaloid Oxytocin Reduces Anxiety in the Valproate-Induced Autism Rat Model
by: Kristóf László, et al.
Published: (2022-02-01)

Effect of Sodium Valproate on the Conformational Stability of the Visual G Protein-Coupled Receptor Rhodopsin
by: Neda Razzaghi, et al.
Published: (2021-05-01)

Comprehensive Analysis of Metabolic Changes in Male Mice Exposed to Sodium Valproate Based on GC-MS Analysis
by: Gao Y, et al.
Published: (2022-06-01)

Interaction of Sodium Valproate With Low-Frequency Electrical Stimulation During Kindlingn
by: Raha Zalkhani, et al.
Published: (2020-11-01)

EXPERIENCE GENERIC VALPROATE IN ADULTS WITH FOCAL EPILEPSY (RESULTS THE OBSERVATIONS IN MOSCOW HEALTH FACILITY OUTPATIENT NETWORK)
by: I. Yu. Artemova, et al.
Published: (2016-05-01)

PHARMACO-ECONOMIC EVALUATION OF THE USE OF VALPROATES IN TABLET FORMS IN EPILEPSY THERAPY
by: P. A. Balunov
Published: (2017-05-01)

Trio-Drug Combination of Sodium Valproate, Baclofen and Thymoquinone Exhibits Synergistic Anticonvulsant Effects in Rats and Neuro-Protective Effects in HEK-293 Cells
by: Faheem Hyder Pottoo, et al.
Published: (2022-09-01)